Evidence map›Paper›PMID 29439965›Full record

ArticleAntimicrobial agents and chemotherapy2018

Next-Generation Sequencing and Bioinformatics Protocol for Malaria Drug Resistance Marker Surveillance.

Eldin Talundzic, Shashidhar Ravishankar, Julia Kelley, Dhruviben Patel, Mateusz Plucinski, Sarah Schmedes, Dragan Ljolje, Brooke Clemons, Susan Madison-Antenucci, Paul M Arguin and 3 more

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 2 pooled it
9.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 2 syntheses or guidelines pooled it, 82 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. UnderstandingiScience · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. A review on molecular markers ofJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2025
    Review
  14. UnderstandingmedRxiv : the preprint server for health sciences · 2025
    Article
  15. Article
  16. Geo-classification of drug-resistant travel-associatedAntimicrobial agents and chemotherapy · 2024
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Eldin TalundzicMalaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA etalundzic@cdc.gov.
Shashidhar RavishankarSchool of Biology, Georgia Institute of Technology, Atlanta, Georgia, USA.
Julia KelleyAtlanta Research and Education Foundation, VAMC, Atlanta, Georgia, USA.
Dhruviben PatelMalaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Mateusz PlucinskiMalaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Sarah SchmedesMalaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Dragan LjoljeAtlanta Research and Education Foundation, VAMC, Atlanta, Georgia, USA.
Brooke ClemonsParasitology Laboratory, Wadsworth Center, New York State Department of Health, Albany, New York, USA.
Susan Madison-AntenucciParasitology Laboratory, Wadsworth Center, New York State Department of Health, Albany, New York, USA.
Paul M ArguinMalaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Naomi W LucchiMalaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Fredrik VannbergSchool of Biology, Georgia Institute of Technology, Atlanta, Georgia, USA.
Venkatachalam UdhayakumarMalaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Centers for Disease Control and Prevention · USAtlanta Research and Education Foundation · USCenter for Global Health · USGeorgia Institute of Technology · USNew York State Department of Health · USDivision of Parasitic Diseases and Malaria · US

Funding

QUBBD: VIRAL EVOLUTION AND SPREAD OF INFECTIOUS DISEASE IN COMPLEX NETWORK: BIG DATA ANALYSIS AND MODELINGR01EB025022 · NIBIB · GEORGIA STATE UNIVERSITY · PI SKUMS, PAVEL, VANNBERG, FREDRIK · 2017 to 2019
$891k
NIBIB NIH HHS R01 EB025022
6 · The paper itself

Abstract

The recent advances in next-generation sequencing technologies provide a new and effective way of tracking malaria drug-resistant parasites. To take advantage of this technology, an end-to-end Illumina targeted amplicon deep sequencing (TADS) and bioinformatics pipeline for molecular surveillance of drug resistance in

Indexed as

AntimalarialsComputational BiologyDrug ResistanceGenotypeHigh-Throughput Nucleotide SequencingMalariaPlasmodium falciparumPolymorphism, Single NucleotidePyrimethamineSulfadoxineAntimalarialsPyrimethamineSulfadoxinedrug resistancemolecular surveillancenext-generation sequencingP. falciparum

Identifiers

PMID29439965
PMCPMC5913988
OpenAlexW2793378655

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.